MANUEL COBO DOLS – ENSAYO CLINICO COMERCIAL – F. HOFFMANN-LA ROCHE LTD
An open label, multicenter extension study in patients previously enrolled in a Genentch and/or F. Hoffmann-La Roche Ltd sponsored atezolizumab study (IMBRELLA B)
por prodriguez | Jul 3, 2024 | Ensayos Clínicos, Ensayos Clínicos - CIMO-02 | 0 Comentarios